This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (67)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Bacterial Infections  • Infectious Diseases, Other  • Pneumonia  • Alert me on articles by topic  Social Bookmarking   What's this?

Results From the Pneumonia Patient Outcomes Research Team Cohort Study

Eric M. Mortensen, MD, MSc; Christopher M. Coley, MD; Daniel E. Singer, MD; Thomas J. Marrie, MD; D. Scott Obrosky, MSc; Wishwa N. Kapoor, MD, MPH; Michael J. Fine, MD, MSc

Arch Intern Med. 2002;162:1059-1064.

Background  To our knowledge, no previous study has systematically examined pneumonia-related and pneumonia-unrelated mortality. This study was performed to identify the cause(s) of death and to compare the timing and risk factors associated with pneumonia-related and pneumonia-unrelated mortality.

Methods  For all deaths within 90 days of presentation, a synopsis of all events preceding death was independently reviewed by 2 members of a 5-member review panel (C.M.C., D.E.S., T.J.M., W.N.K., and M.J.F.). The underlying and immediate causes of death and whether pneumonia had a major, a minor, or no apparent role in the death were determined using consensus. Death was defined as pneumonia related if pneumonia was the underlying or immediate cause of death or played a major role in the cause of death. Competing-risk Cox proportional hazards regression models were used to identify baseline characteristics associated with mortality.

Results  Patients (944 outpatients and 1343 inpatients) with clinical and radiographic evidence of pneumonia were enrolled, and 208 (9%) died by 90 days. The most frequent immediate causes of death were respiratory failure (38%), cardiac conditions (13%), and infectious conditions (11%); the most frequent underlying causes of death were neurological conditions (29%), malignancies (24%), and cardiac conditions (14%). Mortality was pneumonia related in 110 (53%) of the 208 deaths. Pneumonia-related deaths were 7.7 times more likely to occur within 30 days of presentation compared with pneumonia-unrelated deaths. Factors independently associated with pneumonia-related mortality were hypothermia, altered mental status, elevated serum urea nitrogen level, chronic liver disease, leukopenia, and hypoxemia. Factors independently associated with pneumonia-unrelated mortality were dementia, immunosuppression, active cancer, systolic hypotension, male sex, and multilobar pulmonary infiltrates. Increasing age and evidence of aspiration were independent predictors of both types of mortality.

Conclusions  For patients with community-acquired pneumonia, only half of all deaths are attributable to their acute illness. Differences in the timing of death and risk factors for mortality suggest that future studies of community-acquired pneumonia should differentiate all-cause and pneumonia-related mortality.

From the Division of General Internal Medicine, Department of Medicine, and the Center for Research on Health Care, University of Pittsburgh (Drs Mortensen, Kapoor, and Fine and Mr Obrosky), and the Center for the Study of Health Disparities, VA Pittsburgh Healthcare System (Dr Fine), Pittsburgh, Pa; the General Medicine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston (Drs Coley and Singer); and the Division of Infectious Disease, Department of Medicine, University of Alberta, Edmonton (Dr Marrie).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pneumonia mortality in a UK general practice population cohort
Myles et al.
Eur J Public Health 2009;19:521-526.
ABSTRACT | FULL TEXT  

Green tea and death from pneumonia in Japan: the Ohsaki cohort study
Watanabe et al.
Am. J. Clin. Nutr. 2009;90:672-679.
ABSTRACT | FULL TEXT  

Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia
Menendez et al.
Thorax 2009;64:587-591.
ABSTRACT | FULL TEXT  

Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia
Phua et al.
Thorax 2009;64:598-603.
ABSTRACT | FULL TEXT  

Severity assessment in community-acquired pneumonia: a review
Singanayagam et al.
QJM 2009;102:379-388.
ABSTRACT | FULL TEXT  

Development of a prognostic index for 90-day mortality in patients discharged after admission to hospital for community-acquired pneumonia
Capelastegui et al.
Thorax 2009;64:496-501.
ABSTRACT | FULL TEXT  

Limiting Antibiotic Use in Lower Respiratory Tract Infections: Have We Gone Too Far?
Waterer
Chest 2009;135:1118-1120.
FULL TEXT  

Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia
Restrepo et al.
Eur Respir J 2009;33:153-159.
ABSTRACT | FULL TEXT  

Review: Novel targets in the management of pneumonia
Diaz et al.
Ther Adv Respir Dis 2008;2:387-400.
ABSTRACT  

Incidence, Etiology, Timing, and Risk Factors for Clinical Failure in Hospitalized Patients With Community-Acquired Pneumonia
Aliberti et al.
Chest 2008;134:955-962.
ABSTRACT | FULL TEXT  

Preadmission Use of Statins and Outcomes After Hospitalization With Pneumonia: Population-Based Cohort Study of 29 900 Patients
Thomsen et al.
Arch Intern Med 2008;168:2081-2087.
ABSTRACT | FULL TEXT  

Early mortality in patients with community-acquired pneumonia: causes and risk factors
Garcia-Vidal et al.
Eur Respir J 2008;32:733-739.
ABSTRACT | FULL TEXT  

Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment
Kothe et al.
Eur Respir J 2008;32:139-146.
ABSTRACT | FULL TEXT  

Inflammatory Markers at Hospital Discharge Predict Subsequent Mortality after Pneumonia and Sepsis
Yende et al.
Am. J. Respir. Crit. Care Med. 2008;177:1242-1247.
ABSTRACT | FULL TEXT  

Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia
Mortensen et al.
Eur Respir J 2008;31:611-617.
ABSTRACT | FULL TEXT  

A Comparative Study of Community-Acquired Pneumonia Patients Admitted to the Ward and the ICU
Restrepo et al.
Chest 2008;133:610-617.
ABSTRACT | FULL TEXT  

Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Risk and Outcome of Pneumonia
van de Garde et al.
Chest 2008;133:220-225.
ABSTRACT | FULL TEXT  

Free and Total Cortisol Levels as Predictors of Severity and Outcome in Community-acquired Pneumonia
Christ-Crain et al.
Am. J. Respir. Crit. Care Med. 2007;176:913-920.
ABSTRACT | FULL TEXT  

Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia
Schaaf et al.
Eur Respir J 2007;30:517-524.
ABSTRACT | FULL TEXT  

Type 2 Diabetes and Pneumonia Outcomes: A population-based cohort study
Kornum et al.
Diabetes Care 2007;30:2251-2257.
ABSTRACT | FULL TEXT  

Is co-morbidity taken into account in the antibiotic management of elderly patients with acute bronchitis and COPD exacerbations?
Bont et al.
Fam Pract 2007;24:317-322.
ABSTRACT | FULL TEXT  

A prediction rule for elderly primary-care patients with lower respiratory tract infections
Bont et al.
Eur Respir J 2007;29:969-975.
ABSTRACT | FULL TEXT  

Statins and outcomes in patients with pneumonia: Not only healthy user bias
Mortensen et al.
BMJ 2006;333:1123-1124.
FULL TEXT  

Statin treatment and reduced risk of pneumonia in patients with diabetes
van de Garde et al.
Thorax 2006;61:957-961.
ABSTRACT | FULL TEXT  

COPD is associated with increased mortality in patients with community-acquired pneumonia
Restrepo et al.
Eur Respir J 2006;28:346-351.
ABSTRACT | FULL TEXT  

Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia: A Randomized Trial
Christ-Crain et al.
Am. J. Respir. Crit. Care Med. 2006;174:84-93.
ABSTRACT | FULL TEXT  

Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population
van de Garde et al.
Eur Respir J 2006;27:1217-1222.
ABSTRACT | FULL TEXT  

Impact of Alcohol Abuse in the Etiology and Severity of Community-Acquired Pneumonia
de Roux et al.
Chest 2006;129:1219-1225.
ABSTRACT | FULL TEXT  

Impact of initial antibiotic choice on mortality from pneumococcal pneumonia
Aspa et al.
Eur Respir J 2006;27:1010-1019.
ABSTRACT | FULL TEXT  

Guidelines for the Treatment of Community-acquired Pneumonia: Predictors of Adherence and Outcome
Menendez et al.
Am. J. Respir. Crit. Care Med. 2005;172:757-762.
ABSTRACT | FULL TEXT  

Timing of Antibiotic Administration and Outcomes for Medicare Patients Hospitalized With Community-Acquired Pneumonia
Houck et al.
Arch Intern Med 2004;164:637-644.
ABSTRACT | FULL TEXT  

Causes and Factors Associated With Early Failure in Hospitalized Patients With Community-Acquired Pneumonia
Roson et al.
Arch Intern Med 2004;164:502-508.
ABSTRACT | FULL TEXT  

Deaths in risk classes I-III: a measure of quality of care in patients hospitalised with CAP?
Marrie
Eur Respir J 2004;23:103-105.
ABSTRACT | FULL TEXT  

A prediction rule to identify allocation of inpatient care in community-acquired pneumonia
Espana et al.
Eur Respir J 2003;21:695-701.
ABSTRACT | FULL TEXT  

Causes of Death for Patients With Community-Acquired Pneumonia
Stralin et al.
Arch Intern Med 2002;162:2491-2493.
FULL TEXT  

Severe Community-acquired Pneumonia: Use of Intensive Care Services and Evaluation of American and British Thoracic Society Diagnostic Criteria
Angus et al.
Am. J. Respir. Crit. Care Med. 2002;166:717-723.
ABSTRACT | FULL TEXT